Vascular Solutions Inc. Reaches New 12-Month High at $23.89 (VASC)
Vascular Solutions (NASDAQ:VASC)’s share price reached a new 52-week high during trading on Monday, Analyst Ratings Network reports. The stock traded as high as $23.89 and last traded at $23.35, with a volume of 78,241 shares traded. The stock had previously closed at $23.16.
VASC has been the subject of a number of recent research reports. Analysts at Feltl & Co. raised their price target on shares of Vascular Solutions from $21.00 to $23.00 in a research note to investors on Thursday, December 12th. They now have a “buy” rating on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of Vascular Solutions from $21.00 to $22.50 in a research note to investors on Wednesday, October 23rd. They now have a “buy” rating on the stock. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Vascular Solutions presently has a consensus rating of “Buy” and an average price target of $20.50.
Vascular Solutions has a 52-week low of $13.92 and a 52-week high of $23.89. The stock’s 50-day moving average is $21.05 and its 200-day moving average is $17.86. The company has a market cap of $394.5 million and a P/E ratio of 36.82.
Vascular Solutions (NASDAQ:VASC) last released its earnings data on Tuesday, October 22nd. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.12. The company had revenue of $28.01 million for the quarter, compared to the consensus estimate of $27.10 million. During the same quarter in the previous year, the company posted $0.16 earnings per share. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. On average, analysts predict that Vascular Solutions will post $0.70 earnings per share for the current fiscal year.
Vascular Solutions, Inc (NASDAQ:VASC) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.